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Abstract
Background: It is well known that the hippocampus, the CA1 Pyramidal cells in particular, is se-
lectively vulnerable during global cerebral ischemia. Recently, it is observed that pentoxifylline has a
neuroprotective effect. This study explored the pharmacological relationship between ischemia-
induced cell death of the hippocampus and the efficacy of a vasodilator agent (pentoxifylline) in the
prevention of delayed neuronal death.
Methods: This experimental study was performed on 4 groups: control, ischemia, experimental
(200mg/kg pentoxifylline injection one hour prior to and one hour following ischemia) and vehicle
(normal saline). Transient global ischemia was induced by bilateral common carotid arteries occlu-
sion. To investigate the apoptotic bodies and caspase-3 activities as a central role in the execution
phase of apoptosis, the brains were prepared for the TUNEL technique.
Results: Pentoxifylline administration limited apoptosis and caspase-3 activities in rats’ hippocam-
pi. Our data showed no significant difference between the number of apoptotic bodies in the CA1
region of the hippocampus in the control and pentoxifylline -treated groups (p= 0.994).  The results
of one- way ANOVA revealed that that ischemia significantly increased caspase-3 levels in the hip-
pocampus (p< 0.05); however, the level of caspase-3 in pentoxifylline -treated rats was less than the
ischemic group.
Conclusion: These results suggest that the neuroprotective effect of pentoxifylline (200mg/kg) may
be accompanied by a reduction in ischemic damage within the CA1 region of the hippocampus in
rats subjected to transient global cerebral ischemia.
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Introduction
Stroke due to ischemia is the third cause
of death and the leading cause of perma-
nent disability in adults’ worldwide. The
leading pathogenic mechanisms of cerebral
ischemia include energy failure, elevation
of intracellular Ca2+ level, glutamate medi-
ated excitotoxicity, release of reactive oxy-
gen species (ROS), blood brain barrier dis-
ruption, spreading depression, inflammato-
ry response and apoptosis (1-3). Due to the
advances in intravascular techniques and
thrombolytic agents, transient global cere-
bral ischemia is one of the most common
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types of ischemic stroke observed. Collino
has utilized the 2-vessel occlusion model to
evaluate the histopathology of ischemia.
With this model, injury occurs within selec-
tively vulnerable areas such as the CA1 py-
ramidal neurons of the hippocampus by oc-
clusion of bilateral common carotid (4). In
the brain, the effects of ischemia primarily
target the hippocampus. Within the hippo-
campus, the CA1 pyramidal cells are
known to play a key role in learning and
memory. Apoptosis of these cells causes
neurological deficits as a result of transient
global ischemia (5). Apoptotic neuronal
cell death can be limited by inhibiting mac-
romolecular synthesis and caspase activity
(6). Clinical trials that have investigated
pharmacological neuroprotective strategies
for strokes have shown disappointing re-
sults (7). Thus, to improve the clinical out-
comes in patients who have experienced
brain ischemia, it is necessary to develop
innovative treatment strategies to protect
the brain against the detrimental effects of
this type of injury. Recently, an experi-
mental study in animals has discovered a
beneficial effect of pentoxifylline (PTX) on
functional outcome following ischemic
stroke (8). PTX, a methylxanthine deriva-
tive and nonspecific type 4 phosphodiester-
ase inhibitor, is a drug widely used to man-
age peripheral arterial disease, particularly
in cases of intermittent claudication (9).
The mechanism of action of this drug ap-
pears to be related to the improvement of
cellular functions and plasma modifications
which result in improvements in the micro-
circulation of peripheral and cerebral vas-
cular beds (8). Recently, the therapeutic
potential for PTX as an anti-inflammatory
and immunomodulator agent has been es-
tablished in vivo and in vitro experiments
(10, 11). PTX treatment has been shown to
reduce ischemia-reperfusion injuries to the
lungs (12), liver (13), kidneys (14), spinal
cord (15) and brain in animals such as rats,
mice and dogs (8,16). However, these stud-
ies have not provided detailed information
about the mechanisms underlying the neu-
roprotective effect of PTX. The aim of this
study was to examine the neuroprotective
effect of PTX on cell apoptosis and expres-
sion of caspase-3 in a rat model of transient
global cerebral ischemia.
Methods
Sample
Adult male Wistar rats, 12-13 weeks-old
that weighed between 250-300 g were ac-
quired from the Pharmacology Department
of Tehran University of Medical Sciences
and were used for all experiments. The rats
were housed in standard animal houses and
kept on a 12- hour light/dark cycle. All an-
imals were maintained in the animal house
for at least five days prior to conduction of
the experiments and allowed free access to
food and water.
All study-related procedures were ap-
proved by the Ethics Committee for the
Use of Experimental Animals of Tehran
University of Medical Sciences.
PTX powder was gifted by Amin Phar-
maceutical Co. (Esfehan, Iran).
Experimental Groups and Drugs:
In this experimental study, the animals
(n= 40) were randomly divided into four
groups. The control group rats were anes-
thetized with pentobarbital sodium
(40mg/kg) and received no additional
treatments. Bilateral common carotid oc-
clusion (20 minutes) followed by reperfu-
sion were performed for the 3 remaining
groups (ischemia, experimental and vehicle
groups). The experimental group rats were
treated as same as the ischemia group ex-
cept for receiving intraperitoneal (IP) injec-
tions of 200 mg/kg PTX one hour prior to
and one hour after ischemia. Rats in the
vehicle group were treated as same as the
ischemia group but they were given IP in-
jections of normal saline (0.5ml) one hour
prior to and one hour after ischemia. The
animals were sacrificed after four days. All
hippocampi were removed and prepared for
the TUNEL method and Western blot anal-
ysis.
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Surgical Procedure
We carefully performed transient, global
ischemia. For bilateral occlusion, a ventral
midline incision was made to expose both
carotid arteries which were then gently iso-
lated from the carotid sheath and vagus
nerve. Each carotid artery was ligated for
20 minutes using Yashargil Aneurism mi-
croclips at a point just below the carotid
bifurcation. During ischemia, the animals
were monitored for body temperature, loss
of righting reflex and unresponsiveness to
gentle touch. Subsequently, the carotid ar-
teries were released and inspected for im-
mediate reperfusion by removal of the clips
and restoration of blood flow. Animals
were returned to their home cage following
surgery and maintained separately for four
days (96 hours) after which they were
killed by decapitation (8).
Histopathology
The rats were deeply anesthetized with
pentobarbital (40mg/kg, IP) and their brains
were fixed by cardiac perfusion with 4%
paraformaldehyde buffered with 0.1 mol/L
phosphate buffer (pH 7.2) that contained
4% sucrose. For light microscopy, the brain
tissues were quickly removed and further
immersed in the same fixative for at least
three days. The samples processed for the
TUNEL technique were embedded in par-
affin, cut into 3 µm thick coronal sections
by a rotary microtome, and then placed on
silane-coated glass slides.
TUNEL Technique
To detect apoptotic cells, TUNEL stain-
ing was performed using an In Situ Cell
Death Detection Kit (Cat No:
11684817910, Roche, Mannheim, Germa-
ny) according to the manufacturer’s proto-
col. The sections were deparafinized in xy-
lol, rehydrated by a successive series of al-
cohol, washed in phosphate-buffered saline
(PBS) and deproteinized (or permeabilized)
by proteinase K (20µg/ml) (Cat No: P2308,
Sigma-Aldrich) for 30 minutes at a room
temperature. Then, sections were rinsed
and incubated with 3% H2O2 in methanol
for 10 minutes in the dark to block endoge-
nous peroxidase (POD). Next, sections
were allowed to incubate in the TUNEL
reaction mixture for 60 minutes at 37ºC in a
humidified atmosphere, after which they
were rinsed with PBS. The sections were
visualized by a converter-POD for 30
minutes at 37ºC in a humidified atmosphere
in the dark, then rinsed with PBS, followed
by the addition of 50-100 µl  diaminoben-
zidine (DAB, Cat No: D8001, Sigma-
Aldrich) substrate and an additional PBS
rinse (17).
Western Blot Analysis
Fresh hippocampi were homogenized in
ice-cold lysis buffer that contained tris HCl
(50mM, pH 8.0), NaCl (150mM), Nonidet
P-40 (1%), glycerol (10%), phenylmethyl-
sulfonyl fluoride (10l/ml), sodium deoxy-
cholate (0.5%) and aprotinin (30l/ml), in
addition to a protease inhibitor cocktail
(Roche Applied Science, Cat No:
11697498001). The homogenized hippo-
campi were subjected to centrifugation at
12000 g for 20 minutes at 4oC and the su-
pernatant was collected. A total of 100 µg
from the total protein of the supernatant
was loaded onto each lane and electro-
phoresed on SDS-PAGE gels (10%). Pro-
teins were transferred onto nitrocellulose
membranes for one hour at a room tem-
perature and were blocked with PBS that
contained non-fat dried milk powder (5%)
for two hours.  The membranes were
washed by tris buffer that contained Tween
20 (1%), and then were probed with a
monoclonal anti-cas3 antibody (1:1000;
Abcam, St. Louis, MO, USA, Cat No:
AB32351) overnight after which a second-
ary anti-rabbit akp-linked antibody
(1:10000; Abcam, St. Louis, MO, USA,
Cat No: AB6796) was added for one hour
at a room temperature; then the membranes
were stained with BCIP/NBT. β-actin
served as a positive control for protein
loading, and a high range molecular weight
standard was used to determine protein siz-
es. Results were evaluated by the UVIdoc
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program. (UVIdoc version 12.6 for Win-
dows, copyright 2004) (18).
Statistical Analysis
The results are given as means±SD. The
Significant difference level was determined
by one-way ANOVA, followed by Tukey's
Multiple Comparison test. Statistical signif-
icance was set at p≤ 0.05.
Results
TUNEL Staining for Apoptotic Neurons
in the Hippocampus
The number of TUNEL-positive cells was
significantly elevated in the CA1 region of
the hippocampus in the ischemia group
compared to the control group (p= 0.045).
There was a significant difference between
the control and vehicle groups (p= 0.02);
however, no significant difference was ob-
served between the control and PTX-
treated groups (p= 0.994), meaning that
apoptotic cells significantly decreased fol-
lowing PTX treatment. Figs. 1 and 2
demonstrate representative TUNEL-
positive apoptotic cells and the relationship
of PTX treatment on the numbers of apop-
totic cell bodies in the CA1 region of the
hippocampus.
Western Blot Technique
The level of caspase-3 enzymatic activity
as an initiator factor of apoptosis was
measured by Western blot. The levels of
caspase-3 activity were markedly increased
in the hippocampi of the ischemia group
compared to the control group. Caspase-3
levels were elevated in the hippocampi
from the vehicle group, whereas the PTX-
treated group had lower levels compared to
those of the ischemia group (Fig. 3). These
results showed that ischemia significantly
increased caspase-3 levels in the hippo-
campus (p< 0.05); however, the level of
caspase-3 in the PTX-treated group was
less than observed in the ischemia group.
Discussion
Brain damage from ischemia is divided
into two phases, the first of which is acute
damage that leads to neuronal cell death.
The main pathophysiologic mechanisms of
ischemia include energy metabolism dis-
turbance, calcium overload, and the pro-
duction of oxygen-free radicals, nitric ox-
ide, neurotoxic excitatory amino acids and
destruction of the blood brain barrier
(BBB). The second phase is delayed neu-
ronal damage (DND) in which cerebral is-
Fig. 1. Photomicrographs of coronal sections of CA1 region of hippocampus .Arrows show apoptotic bodies. (Tunel
Staining, Scale bar=30µm)
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chemia-reperfusion stimulates an inflam-
matory reaction and apoptosis, and it is the
main pathophysiologic mechanisms of
DND (19).
Global ischemia-reperfusion injury is
characterized by the deterioration of brain
Fig. 2. Comparison the mean of apoptotic bodies in vehicle, experimental, ischemia and control groups according to
TUNEL assay. The mean of apoptotic bodies significantly decreased in the hippocampus of experimental group following
PTX (200mg/kg) treatment (p< 0.05) vs. control group. There was no statistical difference between number of apoptotic
bodies in control and experimental groups. Results are the mean ± SEM.
Fig. 3. Protein expression of cleaved caspase 3 in the hippocampus of vehicle, experimental, ischemia and control groups
by western blot. * Expression of caspase-3 protein significantly decreased in the hippocampus of experimental group
following PTX (200mg/kg) treatment vs. ischemia and vehicle groups (p≤ 0.05). Values are mean± S.E.M.
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tissue following reperfusion (20). Many
patients suffer from various degrees of
learning and memory dysfunction which is
indicative of impairment in the hippocam-
pus, the primary area of the brain that con-
trols the formation of learned behaviors and
memories (21). It has been reported that the
hippocampus, the CA1 region in particular,
is selectively vulnerable during global cer-
ebral ischemia (22).
Many studies have demonstrated that
apoptosis during ischemia/reperfusion (I/R)
plays a major role in stroke-associated
brain injury (23). Apoptosis or programmed
cell death when compared with necrosis is
associated with less inflammation (24).
Apoptotic cells are phagocytized by mac-
rophages before their membrane breaks
down; thus, their intracellular enzymes are
not released. Apoptosis is triggered by two
pathways: the intrinsic pathway which in-
volves the mitochondria and is activated by
reactive oxygen species and the extrinsic
pathway that is activated when ligands bind
to their receptors. An example of the ex-
trinsic pathway is tumor necrosis factor-
alpha (TNF-α) that binds to TNF-receptors
and the Fas-ligand that binds to Fas (25).
We aimed to evaluate the effects of post-
ischemic treatment of PTX on ischemic
damage and neurological deficits in the rat
model of transient global cerebral ischemia.
PTX at a dose of 200 mg/kg was selected
based on our previous study. We have pre-
viously reported that pre-ischemic treat-
ment of PTX at a dose of 200 mg/kg (IP)
could attenuate spatial memory impairment
(8).
The results of the current study are also
consistent with those of another report
which have demonstrated that post-
ischemic treatment of PTX at a dose of 40
mg/kg (IP) caused a reduction in cortical
damage in rats (26). Additionally, our find-
ings were in agreement with preclinical
studies that demonstrated treatment with
PTX reduced neuronal damage following
ischemia (27).
TNF-α is a pro-inflammatory cytokine
that plays an important role in the events
following ischemia. The level of TNF-α
increases during certain pathological condi-
tions such as infectious, as well as neuro-
logical, neurodegenerative and neurotoxic
conditions (28).
Numerous researches have shown the ex-
pression of TNF-α in ischemic neurons af-
ter cerebral ischemia (29). TNF-α mRNA
becomes upregulated within 30 minutes in
the ischemic brain, reaching a peak at 6–12
hour post-ischemia (30, 31).
PTX is a phosphodiesterase inhibitor that
penetrates the blood–brain barrier which
inhibits the production of TNF-α and other
pro-inflammatory cytokines (32). It is well-
known that TNF-α and glutamate can act
synergistically to induce neuronal cell
death (31). TNF-α can block glutamate
transporter activity and induce glutamate
neurotoxicity, which appears to be an im-
portant mechanism for neurodegeneration
associated with inflammation. Recently, a
wide range of anti-inflammatory properties
have been ascribed to PTX such as inhibi-
tion of neutrophil activation, attenuation of
inflammatory mediator production and pre-
vention of endothelial-leukocyte adhesion
(33). Vakilli et al. have observed that PTX
significantly reduced the concentration of
TNF-α in an ischemic brain cortex up to 4
hours post-transient focal stroke (34). In
this study, we have hypothesized that at
least a part of the neuroprotective effects of
PTX is possibly related to the inhibition of
TNF-α synthesis. In addition, the neuropro-
tective  effect of PTX might be related to
its ability to increase cerebral blood flow
and neutrophil inhibition (35), reduce the
release of inflammatory mediators such as
platelet-activating factors and prevent en-
dothelial–leukocyte adhesion (36). Perhaps
PTX has the ability to inhibit free radical
generation.
The present study showed that PTX can
prevent neuronal apoptosis and thus caus-
ing a decrease in the numbers of damaged
neurons in the neural tissue. However, pre-
vious studies are about focal brain ischemia
and gene expression in apoptosis. However,
in global brain ischemia model, injury oc-
Z. Nadia Sharifi, et al.
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curs within selectively vulnerable areas
such as the CA1 pyramidal neurons (as our
study) and 2 vessel occlusion (common ca-
rotid artery occlusion) is a suitable model
to evaluate histopathology consequences
from brain ischemia (37). TNF-α activates
the caspase protease family cascade reac-
tion. The caspase family promotes apopto-
sis in mammalian cells. Caspase-3 is acti-
vated in the apoptotic cell both by extrinsic
(dead ligand) and intrinsic (mitochondrial)
pathways (38). A variety of extracellular
signals activate caspase-8 through the Fas
receptor pathway and caspase-9 via mito-
chondrial cytochrome C in cerebral ische-
mia reperfusion injuries. The activation of
caspase-8 and caspase- 9 then promote
caspase-3, which in turn hydrolyzes cell-
specific proteins and poly-ADP ribose pol-
ymerase (PARP), inducing apoptosis (39).
Thus, caspase-3 activity and TUNEL stain-
ing are different measures of apoptosis.
Conclusion
Our studies showed that the global is-
chemia insult for 20 minutes caused abun-
dant neuronal cell death and apoptosis in
the hippocampal CA1 region. However,
when the animals were treated with PTX,
there were lower numbers of TUNEL-
positive cells in the hippocampus CA1 re-
gion compared to the ischemia group.
We further noted that PTX treatment
down-regulated the expression of cleaved
caspase-3 in the hippocampus. Possibly,
PTX has an anti-apoptotic effect in ische-
mia reperfusion injury. To clarify the neu-
roprotective mechanism of PTX, we inves-
tigated the expressions of key apoptosis-
related molecules and determined that
cleaved caspase-3 increased in the ischemia
group following global cerebral ischemia.
However, it significantly decreased in the
PTX (200mg/kg) treatment group relative
to the vehicle and ischemia groups.
Our results revealed that PTX improves
the outcome after global cerebral ischemia.
This effect appears to be related to the anti-
apoptotic action of PTX.
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